NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathwayShuzhi Cui(Guangzhou Women and Children Medical Center), Yu Wei(Institut Pasteur)Nature CommunicationsDecember 19, 202310.1038/s41467-023-44201-2Cited by 21SaveCiteExport RISWatch citationsRelated PapersCDC42 supports HBV entry by NTCP translocation to the plasma membrane and macropinocytosis|EMBO Reports|2025|2NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway|Research Square|2023|1